EUVIMEDEUVIMED entdecken
Crossref

Chemical Diversity of Aspergillus alliaceus Phenotypes: Discovery of Brominated Bianthrones with Activity against Triple‐Negative Breast Cancer Cell Lines

Paige E Mandelare iD, Samantha S Yee iD, Daniel G Icenhour iD, Elizabeth N Kaweesa iD, Mark McCauley iD, April L Risinger iD, Jeffrey D Rudolf iD, Sandra Loesgen iD

ChemBioChem · 2024

DOI: 10.1002/cbic.202400398 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemBioChem, 2024. Verfasst von Paige E Mandelare und 7 weiteren Autor:innen. Beteiligte Einrichtung: Whitney Laboratory for Marine Bioscience, University of Florida, St. Augustine, FL, USA. Hauptthemen laut MEDLINE: Aspergillus, Triple Negative Breast Neoplasms, Antineoplastic Agents, Cell Proliferation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 93 Literaturangaben. Gefördert von: National Science Foundation, National Science Foundation Graduate Research Fellowship.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Marine‐derived fungi have emerged as a source for novel metabolites with a broad range of bioactivities. However, accessing the full potential of fungi under standard laboratory conditions remains challenging. LC–MS‐based metabolomics in combination with varied culture conditions is a fast and powerful tool to detect new metabolites. Here, three developmental forms of the marine‐derived fungus Aspergillus alliaceus were analyzed and 14 fungal metabolites, including new brominated polyketides ( 11‐14 ) were isolated. Structure elucidation relied mainly on 1D and 2D NMR techniques and was supported by low‐ and high‐resolution mass spectrometry and DFT‐based computations. We sequenced the A. alliaceus genome, identified the bianthrone‐producing biosynthetic gene cluster, and conducted expression analysis on genes involved in sexual development and biosynthesis. The NCI‐60 cell line panel revealed selective in vitro activity against triple‐negative breast cancer (TNBC) for the halogenated allianthrones and their full antiproliferative and cytotoxic effects were evaluated in five TNBC cell lines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AspergillusTriple Negative Breast NeoplasmsAntineoplastic AgentsCell ProliferationHalogenationDrug Screening Assays, AntitumorHumansCell Line, TumorMolecular StructurePhenotypeMultigene Family

Stichwörter der Autor:innen

bianthronesfungal natural productsgenome miningmetabolomicstriple-negative breast cancer

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Whitney Laboratory for Marine Bioscience, University of Florida, St. Augustine, FL, USA.
  • Department of Pharmacology and Mays Cancer Center, The University of Texas Health Science Center, San Antonio, TX, USA.
  • Department of Chemistry, University of Florida, Gainesville, FL, USA.

ORCID-Profile: Paige E Mandelare, Samantha S Yee, Daniel G Icenhour, Elizabeth N Kaweesa, Mark McCauley, April L Risinger, Jeffrey D Rudolf, Sandra Loesgen

Förderung

  • National Science Foundation
  • National Science Foundation Graduate Research Fellowship

Zitieren

APA

Mandelare, P. E., Yee, S. S., Icenhour, D. G., Kaweesa, E. N., McCauley, M., Risinger, A. L., Rudolf, J. D., & Loesgen, S. (2024). Chemical Diversity of Aspergillus alliaceus Phenotypes: Discovery of Brominated Bianthrones with Activity against Triple‐Negative Breast Cancer Cell Lines. ChemBioChem. https://doi.org/10.1002/cbic.202400398

Vancouver

Mandelare PE, Yee SS, Icenhour DG, Kaweesa EN, McCauley M, Risinger AL, et al. Chemical Diversity of Aspergillus alliaceus Phenotypes: Discovery of Brominated Bianthrones with Activity against Triple‐Negative Breast Cancer Cell Lines. ChemBioChem. 2024. doi:10.1002/cbic.202400398

BibTeX
@article{Mandelare2024,
  author = {Mandelare, Paige E and Yee, Samantha S and Icenhour, Daniel G and Kaweesa, Elizabeth N and McCauley, Mark and Risinger, April L and Rudolf, Jeffrey D and Loesgen, Sandra},
  title = {Chemical Diversity of Aspergillus alliaceus Phenotypes: Discovery of Brominated Bianthrones with Activity against Triple‐Negative Breast Cancer Cell Lines},
  journal = {ChemBioChem},
  year = {2024},
  doi = {10.1002/cbic.202400398}
}
Kostenlos starten →